102 related articles for article (PubMed ID: 28274166)
1. Serum endothelin-1 and placental alkaline phosphatase levels in placenta percreta and normal pregnancies.
Uyanikoglu H; Turp AB; Hilali NG; Incebiyik A
J Matern Fetal Neonatal Med; 2018 Mar; 31(6):777-782. PubMed ID: 28274166
[TBL] [Abstract][Full Text] [Related]
2. Trophoblastic E-cadherin and TGF-beta expression in placenta percreta and normal pregnancies.
Incebiyik A; Kocarslan S; Camuzcuoglu A; Hilali NG; Incebiyik H; Camuzcuoglu H
J Matern Fetal Neonatal Med; 2016; 29(1):126-9. PubMed ID: 25471088
[TBL] [Abstract][Full Text] [Related]
3. Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta.
Uyanıkoğlu H; İncebıyık A; Turp AB; Çakmak G; Sak S; Hilali NG
Balkan Med J; 2018 Jan; 35(1):55-60. PubMed ID: 28903888
[TBL] [Abstract][Full Text] [Related]
4. What is the role of matrix metalloproteinase-2 in placenta percreta?
Kocarslan S; Incebıyık A; Guldur ME; Ekinci T; Ozardali HI
J Obstet Gynaecol Res; 2015 Jul; 41(7):1018-22. PubMed ID: 25656855
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta.
Tseng JJ; Hsu SL; Ho ES; Hsieh YT; Wen MC; Chou MM
Am J Obstet Gynecol; 2006 Feb; 194(2):564-71. PubMed ID: 16458662
[TBL] [Abstract][Full Text] [Related]
6. Senescence and Telomere Homeostasis Might Be Involved in Placenta Percreta-Preliminary Investigation.
Tzadikevitch Geffen K; Gal H; Vainer I; Markovitch O; Amiel A; Krizhanovsky V; Biron-Shental T
Reprod Sci; 2018 Aug; 25(8):1254-1260. PubMed ID: 29108468
[TBL] [Abstract][Full Text] [Related]
7. Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.
Oztas E; Ozler S; Ersoy AO; Ersoy E; Caglar AT; Uygur D; Yucel A; Ergin M; Danisman N
Placenta; 2016 Mar; 39():1-6. PubMed ID: 26992667
[TBL] [Abstract][Full Text] [Related]
8. Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies.
Mitchell MI; Khalil M; Ben-Dov IZ; Alverez-Perez J; Illsley NP; Zamudio S; Al-Khan A; Loudig O
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791142
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between neurokinin B and endothelin-1 and hypertensive disorders complicating pregnancy].
Li ZM; Zhao Y; Chen Q; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):584-8. PubMed ID: 19087492
[TBL] [Abstract][Full Text] [Related]
10. Fetal gender affects maternal serum total and placental alkaline phosphatase levels during pregnancy.
Gol M; Sisman AR; Guclu S; Altunyurt S; Onvural B; Demir N
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):253-6. PubMed ID: 16332408
[TBL] [Abstract][Full Text] [Related]
11. Shear-wave elastography for detection of placenta percreta: a case-controlled study.
Dokumaci DS; Uyanikoglu H
Acta Radiol; 2022 Mar; 63(3):424-430. PubMed ID: 33626875
[TBL] [Abstract][Full Text] [Related]
12. The clinical outcome of cesarean scar pregnancies implanted "on the scar" versus "in the niche".
Kaelin Agten A; Cali G; Monteagudo A; Oviedo J; Ramos J; Timor-Tritsch I
Am J Obstet Gynecol; 2017 May; 216(5):510.e1-510.e6. PubMed ID: 28115056
[TBL] [Abstract][Full Text] [Related]
13. The role of osteopontin in the pathogenesis of placenta percreta.
Özer A; Yaylalı A; Koçarslan S
Ginekol Pol; 2018; 89(8):437-41. PubMed ID: 30215463
[TBL] [Abstract][Full Text] [Related]
14. Serum angiogenic profile in abnormal placentation.
Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
[TBL] [Abstract][Full Text] [Related]
15. Placental T-Cadherin Correlates With Trophoblastic Invasion Anomalies: Placenta Percreta and Fetal Growth Restriction.
Biyik I; Metineren H; Ozturk E; Simsek S; Oztas E; Guldur ME; Ince O
Int J Gynecol Pathol; 2023 May; 42(3):293-300. PubMed ID: 36731049
[TBL] [Abstract][Full Text] [Related]
16. Antenatal diagnosis of placenta accreta leads to reduced blood loss.
Tikkanen M; Paavonen J; Loukovaara M; Stefanovic V
Acta Obstet Gynecol Scand; 2011 Oct; 90(10):1140-6. PubMed ID: 21488840
[TBL] [Abstract][Full Text] [Related]
17. Does the presence of placental basal plate myometrial fibres increase the risk of subsequent morbidly adherent placenta: a case-control study.
Miller ES; Linn RL; Ernst LM
BJOG; 2016 Dec; 123(13):2140-2145. PubMed ID: 26265563
[TBL] [Abstract][Full Text] [Related]
18. Cesarean section and placental disorders in subsequent pregnancies--a meta-analysis.
Klar M; Michels KB
J Perinat Med; 2014 Sep; 42(5):571-83. PubMed ID: 24566357
[TBL] [Abstract][Full Text] [Related]
19. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
[TBL] [Abstract][Full Text] [Related]
20. Placenta accreta: depth of invasion and neonatal outcomes.
Seet EL; Kay HH; Wu S; Terplan M
J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2042-5. PubMed ID: 22463851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
